Introduction
CiMaas develops immunotherapy for cancer by optimally engaging the immune system.
Read more about CiMaas Immunotherapy products,
or watch our video.
On Saturday January 11, 2020, CiMaas will appear in a special program on new innovations in medicine. It is part of a production for the RTL-Z program " How it's done". Broadcast time is 17.00.
Kiadis and CiMaas formalize a collaboration on the production of Natural Killer cells for the treatment of cancer
Kiadis and CiMaas, Dutch developers and producers of cell therapy for cancer, have now signed an agreement to co-develop a fast and efficient production process to generate high numbers of Natural Killer Cells with strong capacity to kill tumor cells.
Neuroplast and CiMaas, developers and producers of regenerative cell therapies, are setting up joint shop at the Brightlands Chemelot Campus in Geleen where they will be sharing a new laboratory and office space. Both companies currently employ around 30 people and expect to experience substantial growth.